Correlation Between Cullinan Oncology and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Nuvectis Pharma, you can compare the effects of market volatilities on Cullinan Oncology and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Nuvectis Pharma.
Diversification Opportunities for Cullinan Oncology and Nuvectis Pharma
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cullinan and Nuvectis is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Nuvectis Pharma
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Nuvectis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 2.3 times less risky than Nuvectis Pharma. The stock trades about -0.12 of its potential returns per unit of risk. The Nuvectis Pharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 685.00 in Nuvectis Pharma on September 9, 2024 and sell it today you would lose (198.00) from holding Nuvectis Pharma or give up 28.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cullinan Oncology LLC vs. Nuvectis Pharma
Performance |
Timeline |
Cullinan Oncology LLC |
Nuvectis Pharma |
Cullinan Oncology and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and Nuvectis Pharma
The main advantage of trading using opposite Cullinan Oncology and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |